Sign in

CIK 0001935979

  • Large accelerated filer

Biohaven Ltd.

Sign in to watch
Ticker
BHVN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Virgin Islands, British
Entity type
Operating
Phone
+1 203-404-0410
Business address
215 CHURCH STREET, NEW HAVEN, CT, 06510
Former names
Biohaven Research Ltd.
  1. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,381 shares (to pay taxes)
  2. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 1,117 shares (to pay taxes)
  3. 4 Open-market buy VP, Chief Accounting Officer bought 17,000 shares at $8.52 ($144,770)
  4. 4 Open-market buy Director bought 400,000 shares at $7.50 ($3,000,000)
  5. 4 Open-market buy Director bought 3,333,333 shares at $7.50 ($24,999,998)
  6. 4 Open-market buy Chief Executive Officer bought 666,666 shares at $7.50 ($4,999,995)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 32,700 shares at an average $30.47 ($996,238)
  15. 4/A Open-market buy Director bought 73,170 shares at $41.00 ($2,999,970)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,331 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, Clinical Operations gave up 1,956 shares (to pay taxes)
  18. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 1,117 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 2,561 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 6,805 shares (to pay taxes)

Page 2 of 7 · 130 filings